English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Advances in the treatment of lung cancer
Share :
ELCC 2010
28 Apr - 1 May 2010
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
7 Jun 2010
Views:
9318
Rating:
Save
Rate video
Prof Rafael Rosell - University of Barcelona
Prof Rafael Rosell, speaking at the 2010 ELCC conference, talks about the importance of the ELCC 2010 conference and outlines the advances in lung cancer treatment that he has presented at this year's conference.
Watch Prof Rosell's presentation at ESMO 33 on the benefits of customising erlotinib therapy for NSCLC.
Categories:
Lung & pleura
Targeted molecules
Related Videos
ESMO and WCLC: Latest developments in EGFR mutated NSCLC
Dr Matthew Krebs, Dr Antonio Passaro, Dr Enriqueta Felip and Prof Pascale...
18 Oct 2024
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
Dr Marina Garassino - University of Chicago, Chicago, USA
26 Sep 2024
Amivantamab-lazertinib continue to show benefit as a first-line standard-of...
Dr Marina Garassino - University of Chicago, Chicago, USA
26 Sep 2024
ESMO 2024: Highlights and analysis
Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
16 Sep 2024
Immunotherapy resistance pathways investigated to tailor combination NSCLC...
Prof Pascale Tomasini - Aix-Marseille University, Marseille, France
16 Sep 2024
Mutational-based treatment approach may significantly improve outcomes in...
Dr Andrea Botticelli - Sapienza Università di Roma, Rome, Italy
16 Sep 2024
ESMO 2024: Latest in EGFR mutated NSCLC
Prof Ignacio Gil-Bazo, Dr Mariana Brandão, Prof Benjamin Besse and Prof...
16 Sep 2024
Biomarkers, predictive and prognostic factors of resistance to immunotherapy
Dr Ignacio Gil-Bazo - Fundación Instituto Valenciano de Oncología (FIVO)...
12 Jul 2024
Uncommon genetic aberrations NTRK, RET, NRG
Dr Luis E. Raez - Memorial Cancer Institute, Miami, USA
12 Jul 2024
More from
e
cancer